Tampere University Hospital

Tampere, Etelä-Suomen Lääni 33521

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, HER-2 Positive Breast Cancer, Metastatic Neoplasm

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed